VCEL Q2 2022 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$37M-6.3% YoY

Gross Profit

$23M61.7% margin

Operating Income

-$9M-24.5% margin

Net Income

-$9M-24.2% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$1M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$245M

Total Liabilities

$70M

Stockholders' Equity

$175M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$40M	-6.3%
Gross Profit	$23M	$27M	-15.1%
Operating Income	-$9M	-$4M	-143.6%
Net Income	-$9M	-$4M	-136.7%

Revenue Segments

MACI Implants And Kits Member

$29M100%